MMedication Read More Eli Lilly to offer retatrutide access given earlier to just one patientAugust 4, 2026 Lizzy leads STAT’s coverage of the FDA. Her stories explore the relationship between politics and science at the…
HHealthcare Read More Novo Nordisk shares fall after heart medicine trial resultsJuly 31, 2026 Shares of Novo Nordisk fell as much as 10% on Friday after the drugmaker said a late-stage heart…
HHealthcare Read More Novo Nordisk looks to block Eli Lilly weight-loss drug adsJuly 29, 2026 The Eli Lilly and Novo Nordisk logos. Mike Blake | Tom Little | Reuters Novo Nordisk said on…
MMedication Read More FDA is urged by advocacy group to ban DTC prescription drug adsJuly 23, 2026 Ed’s stories explore prescription drug pricing, affordability and access, as well issues surrounding patents, litigation, and legislation. He…
HHealthcare Read More Eli Lilly will file for approval of retatrutide obesity drug in 2027July 23, 2026 The Eli Lilly logo appears on the company’s office in San Diego, California, Nov. 21, 2025. Mike Blake…
MMedication Read More Barriers may keep Merck’s new cholesterol drug from successJuly 22, 2026 A long-awaited moment in preventive cardiology arrived last week, when enlicitide (which Merck is selling under the name…
HHealthcare Read More What to know about testosterone replacement therapyJuly 20, 2026 US Secretary of Defense Pete Hegseth speaks during a press briefing at the Pentagon in Washington, DC, on…
HHealthcare Read More Market for psychedelic drugs to treat mental health gets a buy signalJuly 19, 2026 Psilocybin mushrooms stand ready for harvest in a humidified “fruiting chamber.” John Moore | Getty Images Thursday’s announcement…
MMedication Read More Ozempic for cats? GLP-1 weight-loss drugs are coming for your fat petJuly 18, 2026 A beautiful, but over weight Maine Coon Cat gets measured around the belly by a vet. Ryersonclark |…
HHealthcare Read More Lilly to acquire AtaiBeckley to advance therapies for treatment-resistant depression and other mental health conditionsJuly 17, 2026 AtaiBeckley’s lead program, BPL-003, is designed to provide durable relief from treatment-resistant depression Acquisition expands Lilly’s neuroscience pipeline…
MMedication Read More Natasha never expected to become addicted to prescribed opioids while battling endometriosisJuly 16, 2026 Natasha Trajkovski was 21 when she was first prescribed opioids. After having a C-section, she was diagnosed with…
HHealth Read More Mwyngil Therapeutics to tackle obesity, but without GLP-1sJuly 16, 2026 Allison covers what hot startups are getting up to, and who’s financing them. She is also co-host of…